Images List Premium Download Classic

Inflammation

Inflammation-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Methods for predicting response to treatment
Interleukin Genetics, Inc.
July 13, 2017 - N°20170198350

The present invention provides stratification methods and kits to identify whether an individual having an inflammation-related disorder has genotype-specific differential expression of il-1, i. E., is a “high” or “low” producer of il-1, such that s/he can be provided an appropriate anti-inflammatory drug and at an appropriate dose. The stratification of ...
Anti-inflammatory treatment via inhibition of endothelial cell kinesin light chain 1, variant 1 (klc1c)
Northwestern University
July 13, 2017 - N°20170198290

Provided herein are compositions and methods for the inhibition of endothelial cell kinesin light chain 1, variant 1 (klc1c) expression and/or activity, and treatment or prevention of inflammation therewith.
Compositions and methods for inhibiting bmp
University Of Houston System
July 13, 2017 - N°20170197968

The present invention provides small-molecule inhibitors of bmp signaling and compositions and methods for inhibiting bmp signaling. These compounds and compositions may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with bmp signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for ...
Inflammation Patent Pack
Download 558+ patent application PDFs
Inflammation Patent Applications
Download 558+ Inflammation-related PDFs
For professional research & prior art discovery
inventor
  • 558+ full patent PDF documents of Inflammation-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Compositions and delivery methods for treating dental infections, inflammation, sensitivity, and for use in dental ...
Universitat Bern
July 13, 2017 - N°20170197070

The present invention provides a method of treating a condition affecting a tooth or periodontium in a subject, comprising administering to the subject's tooth or periodontium a composition comprising biocompatible magnetic, magnetizable, or magnetically responsive agents; and applying an external magnetic field, wherein the magnetic, magnetizable, or magnetically responsive agents migrate to a desired location in response to the externally ...
Medicament
Symrise Ag
July 13, 2017 - N°20170196898

Suggested is a medicament which is particularly useful for preventing, curing or abating of cough and inflammations of the respiratory system, comprising or consisting of active pharmaceutical ingredients and 1,3-propandiol.
Compositions comprising exemestane and novel methods of use
The Johns Hopkins University
July 13, 2017 - N°20170196887

In addition to its potent mechanism-dependent inhibition of estrogen biosynthesis, in accordance with the embodiments of the present invention, it has now been found that exemestane has novel chemoprotective properties which have hitherto not been explicitly recognized. The present invention provides methods for the use of compositions comprising exemestane for chemoprotection against a wide variety of non-mammary tumors (and possibly ...
Inflammation Patent Pack
Download 558+ patent application PDFs
Inflammation Patent Applications
Download 558+ Inflammation-related PDFs
For professional research & prior art discovery
inventor
  • 558+ full patent PDF documents of Inflammation-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Application of topical product using a sonic device
Flexxsonic Corp.
July 13, 2017 - N°20170196801

A method is provided comprising steps for (a) dispensing a topical product having a set of ingredients, wherein the set of ingredients provides pain relief to an affected area of a user; and (b) delivering the topical product via a sonic device to the affected area of a user, wherein the affected area includes joint inflammation, wherein the sonic device ...
Composition containing glycine gracilis oil
Amorepacific Corporation
July 13, 2017 - N°20170196797

Disclosed is a composition containing glycine gracilis oil as an active ingredient and, particularly, a composition having uses of anti-oxidation, anti-aging, anti-wrinkles, whitening, anti-inflammation, anti-acne, moisturization, atopy alleviation, skin barrier improvement, and the like.
Method to draw heat out of a living item caused by burns and / or destructive ...
Amorepacific Corporation
July 13, 2017 - N°20170196729

The current invention uses prior technology commonly known as a heatsink as indicated above. The current invention uses a dome or dish style heat source that when applied against a living heat source it will draw heat out of the living item and dissipate it into the air cooking the living item. The new item added to the current invention ...
Use of il-31ra monoclonal antibodies for treating neuronal inflammation
Zymogenetics, Inc.
July 06, 2017 - N°20170190780

Use of antagonists to il-31ra and osmrb are used to treat inflammation and pain by inhibiting, preventing, reducing, minimizing, limiting or minimizing stimulation in neuronal tissues. Such antagonists include soluble receptors, antibodies and fragments, derivative, or variants thereof. Symptoms such as pain, tingle, sensitization, tickle associated with neuropathies are ameliorated.
Use of il-31 monoclonal antibodies for treating neuronal inflammation
Zymogenetics, Inc.
July 06, 2017 - N°20170190771

Use of antagonists to il-31 are used to treat inflammation and pain by inhibiting, preventing, reducing, minimizing, limiting or minimizing stimulation in neuronal tissues. Such antagonists include antibodies and fragments, derivative, or variants thereof. Symptoms such as pain, tingle, sensitization, tickle associated with neuropathies are ameliorated.
Compositions and methods for inhibiting bmp
The Brigham And Woman's Hospital, Inc.
July 06, 2017 - N°20170190705

The present invention provides small molecules inhibitors of bmp signaling and compositions and methods for inhibiting bmp signaling. These compounds and compositions may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with bmp signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as ...
2-aryl-4-hydroxy-1,3-thiazole derivatives useful as trpm8-inhibitors in treatment of neuralgia, pain, copd and ...
The Brigham And Woman's Hospital, Inc.
July 06, 2017 - N°20170190678

Said compounds are useful in the treatment of diseases associated with activity of trpm8 such as pain, inflammation, ischaemia, neurodegeneration, stroke, psychiatric disorders, itch, irritable bowel diseases, cold induced and/or exacerbated respiratory disorders and urological disorders.
Inflammation Patent Pack
Download 558+ patent application PDFs
Inflammation Patent Applications
Download 558+ Inflammation-related PDFs
For professional research & prior art discovery
inventor
  • 558+ full patent PDF documents of Inflammation-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Dialkyl-phosphinoyl-alkane (dapa) compounds and compositions for treatment of lower gastrointestinal tract disorders
Omeros Corporation
July 06, 2017 - N°20170189428

Heat abstraction from the body's surfaces causes sensations of cold from the skin, orbit, nose, mouth, throat, upper esophagus, airways, and anogenital surfaces. The detection of heat abstraction at these sites is via trpm8, a neuronal protein linked to nerve membranes. Chemical agents that act on trpm8 can also produce sensations of cold, but the surface of the lower gastrointestinal ...
Reversing intestinal inflammation by inhibiting retinoic acid metabolism
The Board Of Trustees Of The Leland Stanford Junior University
July 06, 2017 - N°20170189384

An agent that increases local concentration of retinoic acid (ra) in the intestine through modifying enzymatic pathways involved in ra metabolism is administered in a dose effective to inhibit or reverse production of inflammatory mediators by intestinal dendritic cells and thereby reduce intestinal inflammation and tumor growth associated with intestinal inflammation.
Solid oral formulation of fenretinide
Laurent Pharmaceuticals
July 06, 2017 - N°20170189356

Amorphous solid dispersions suitable for oral delivery comprising fenretinide or an analog thereof and at least one matrix polymer, and processes for making the dispersions, are disclosed. Also disclosed are solid oral formulations comprising the amorphous solid dispersions, as well as uses thereof for the prevention and/or treatment of diseases or conditions treatable by fenretinide, including but not limited ...
System and method for detecting inflammation in a foot
Siren Care, Inc.
July 06, 2017 - N°20170188841

One variation of a method for detecting inflammation in a foot includes: accessing a first temperature measured through a left temperature sensor and a second temperature measured through a right temperature sensor at approximately a first time, the left temperature sensor arranged in a left sock and the right temperature sensor arranged in a right sock worn on the user's ...
Inflammatory eye disorders
Massachusetts Eye And Ear Infirmary
July 06, 2017 - N°20170188814

Provided herein are methods of evaluating efficacy of a treatment in a subject having eye inflammation (e. G., a subject having dry eye syndrome) and selecting a subject for participation in a clinical study. Also provided are methods of treating a subject having eye inflammation (e. G., a subject having dry eye syndrome).
Dd1alpha receptor and uses thereof in immune disorders
The General Hospital Corporation
June 29, 2017 - N°20170184604

Described herein are methods and compositions for treatment of immune-related diseases or disorders by modulating dd1α activity, alone or in combination with modulation of pd-1 activity. In some embodiments, the methods and compositions described herein are directed to treatment of cancer and/or infections (e. G., bacterial infection, and/or fungal infection). In some embodiments, the methods and ...
Personalized therapy of inflammation-associated cancer using methods of assessing the susceptibility of a subject to ...
Medizinische Universität Wien
June 29, 2017 - N°20170184595

The present invention relates to in vitro methods of assessing the susceptibility or responsiveness of a subject to the treatment with an epidermal growth factor receptor (egfr) inhibitor/antagonist, wherein the subject has been diagnosed or suspected of suffering from inflammation-associated. These methods comprise determining the level of expression of egfr in myeloid cells in a sample from the subject, ...
Diagnostics
Ucl Business Plc
June 29, 2017 - N°20170184570

The present invention relates to the detection or diagnosis of infection or inflammation in a patient. In particular, the invention provides methods that allow the detection of markers in a sample from a patient or subject, such as a blood sample, which will indicate whether the patient or subject has an infection or has an inflammatory response.
Loading